Beckman Coulter
This article was originally published in The Gray Sheet
Executive Summary
Firm has no plans to enter coagulation self-testing market following purchase of the CLIA-waived AvoSure hand-held device from Avocet Medical for $3 mil., announced Jan. 7. The AvoSure received FDA clearance in 1998 for physician point-of-care use and in December 1999 for consumer use. Beckman Coulter will market the system to clinics, physician offices, and home health service providers...